{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:46:38Z","timestamp":1789411598763,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejca.2021.07.032","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:38:49Z","timestamp":1629466729000},"page":"93-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-5310","authenticated-orcid":false,"given":"Philipp","family":"Karschnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Vogelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-5127","authenticated-orcid":false,"given":"Martin","family":"van den Bent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-2315","authenticated-orcid":false,"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-0927","authenticated-orcid":false,"given":"Louisa","family":"von Baumgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-174X","authenticated-orcid":false,"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg-Christian","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.07.032_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejca.2021.07.032_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib3","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non-small-cell lung cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib6","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.18632\/oncotarget.27837","article-title":"Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study","volume":"11","author":"Tomasini","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2021.07.032_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2021.07.032_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/2159-8290.CD-18-1489","article-title":"Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases","volume":"9","author":"Fischer","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2021.07.032_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41698-021-00151-w","article-title":"Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma","volume":"5","author":"Jiang","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib10","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S1470-2045(20)30556-8","article-title":"The genomic landscape of breast cancer brain metastases: a systematic review","volume":"22","author":"Morgan","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib11","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S1470-2045(17)30692-7","article-title":"Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group","volume":"19","author":"Alexander","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000333","article-title":"Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG\u2217 study in 380 patients","volume":"8","author":"Amaral","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41582-020-0391-x","article-title":"Management of brain metastases according to molecular subtypes","volume":"16","author":"Soffietti","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ejca.2021.07.032_bib17","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/jid.2015.229","article-title":"Intra- and inter-tumoral homogeneity of BRAF(V600E) mutations in melanoma tumors","volume":"135","author":"Riveiro-Falkenbach","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2021.07.032_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00401-014-1350-7","article-title":"Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues","volume":"128","author":"Berghoff","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejca.2021.07.032_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib20","first-page":"noab094","article-title":"Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)","author":"Tawbi","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2021.04.035","article-title":"Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: the future is now!","volume":"152","author":"Maio","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051078","article-title":"Breast cancer brain metastasis-overview of disease state, treatment options and future perspectives","volume":"13","author":"Watase","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2021.07.032_bib25","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/bcr3244","article-title":"Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain","volume":"14","author":"Duchnowska","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2021.07.032_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021262218151","article-title":"Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease","volume":"61","author":"Pollock","year":"2003","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib28","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.25707","article-title":"Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?","volume":"117","author":"Nieder","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-009-0061-8","article-title":"The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Kalkanis","year":"2010","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib30","doi-asserted-by":"crossref","first-page":"E180","DOI":"10.1093\/neuros\/nyy548","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on treatment options for adults with multiple metastatic brain tumors","volume":"84","author":"Ammirati","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2021.07.032_bib31","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1002\/cam4.3402","article-title":"Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment","volume":"9","author":"Sch\u00f6del","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123618","article-title":"Timing of development of symptomatic brain metastases from non-small cell lung cancer: impact on symptoms, treatment, and survival in the era of molecular treatments","volume":"12","author":"J\u00fcnger","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2021.07.032_bib33","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.3390\/ijms14058708","article-title":"Surgical resection of brain metastases-impact on neurological outcome","volume":"14","author":"Sch\u00f6del","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2021.07.032_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","article-title":"Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib35","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2020-0085","article-title":"Defining treatment-related adverse effects in patients with glioma: distinctive features of pseudoprogression and treatment-induced necrosis","volume":"25","author":"Winter","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib36","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood-2018-12-893396","article-title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","volume":"133","author":"Karschnia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2021.07.032_bib37","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1227\/NEU.0b013e318207a58b","article-title":"What factors predict the response of larger brain metastases to radiosurgery?","volume":"68","author":"Yang","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2021.07.032_bib39","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.ejca.2021.07.032_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30938-0","article-title":"Pharmacologic management of cognitive impairment induced by cancer therapy","volume":"20","author":"Karschnia","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30418-2","article-title":"Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review","volume":"19","author":"Pe","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib43","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1016\/S1470-2045(13)70308-5","article-title":"Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group","volume":"14","author":"Lin","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib46","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/neuonc\/not112","article-title":"Invasion patterns in brain metastases of solid cancers","volume":"15","author":"Berghoff","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib47","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00701-015-2479-4","article-title":"Early postoperative magnet resonance tomography after resection of cerebral metastases","volume":"157","author":"Kamp","year":"2015","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ejca.2021.07.032_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12885-020-06897-z","article-title":"Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee","volume":"20","author":"Kiesel","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3171\/2009.11.JNS09659","article-title":"Factors influencing the risk of local recurrence after resection of a single brain metastasis","volume":"113","author":"Patel","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/JNS\/2008\/108\/2\/0248","article-title":"Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa","volume":"108","author":"Suki","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib51","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1227\/01.NEU.0000341535.53720.3E","article-title":"Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis","volume":"64","author":"Suki","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2021.07.032_bib52","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3171\/2012.1.JNS111560","article-title":"Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection","volume":"116","author":"Ahn","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib53","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3171\/2014.9.JNS13939","article-title":"Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis","volume":"122","author":"Patel","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3171\/2008.8.JNS08448","article-title":"Reduced local recurrence of a single brain metastasis through microscopic total resection","volume":"110","author":"Yoo","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061435","article-title":"The debatable benefit of gross-total resection of brain metastases in a comprehensive treatment setting","volume":"13","author":"J\u00fcnger","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2021.07.032_bib56","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3171\/2016.2.JNS152855","article-title":"Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region","volume":"126","author":"Sanmillan","year":"2017","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib57","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2013.12.FOCUS13464","article-title":"Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases","volume":"36","author":"Marbacher","year":"2014","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ejca.2021.07.032_bib58","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.18632\/oncotarget.27688","article-title":"Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: a matched cohort analysis of the Metastasys study data","volume":"11","author":"Hussein","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2021.07.032_bib59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11060-018-03066-y","article-title":"Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival?","volume":"141","author":"Kamp","year":"2019","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib60","first-page":"1","article-title":"Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases","author":"Marhold","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2021.03.002","article-title":"Evidence-based recommendations on categories for extent of resection in diffuse glioma","volume":"149","author":"Karschnia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.wneu.2016.07.093","article-title":"When the infection hits the wound: matched case-control study in a neurosurgical patient collective including systematic literature review and risk factors analysis","volume":"95","author":"Schipmann","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib63","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp.2006.110023","article-title":"Cognitive outcome in adults after bacterial meningitis","volume":"78","author":"Hoogman","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejca.2021.07.032_bib64","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3171\/2010.10.JNS101042","article-title":"Impact of bevacizumab chemotherapy on craniotomy wound healing","volume":"114","author":"Clark","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00701-011-1221-0","article-title":"Complex wound-healing problems in neurosurgical patients: risk factors, grading and treatment strategy","volume":"154","author":"Krishnan","year":"2012","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ejca.2021.07.032_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000763","article-title":"Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma","volume":"5","author":"Le Rhun","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2021.07.032_bib68","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib69","article-title":"Current status of PET imaging in neuro-oncology","volume":"1","author":"Galldiks","year":"2019","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ejca.2021.07.032_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/neuonc\/noz147","article-title":"Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression","volume":"22","author":"Galldiks","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib71","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2967\/jnumed.120.248278","article-title":"Treatment monitoring of immunotherapy and targeted therapy using (18)F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences","volume":"62","author":"Galldiks","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib72","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/jnnp.2009.174250","article-title":"Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only","volume":"80","author":"Rachinger","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejca.2021.07.032_bib73","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/neuonc\/noz012","article-title":"Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications","volume":"21","author":"Boire","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00701-017-3102-7","article-title":"Serious tumor seeding after brainstem biopsy and its treatment-a case report and review of the literature","volume":"159","author":"Pinggera","year":"2017","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ejca.2021.07.032_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3171\/jns.1997.87.2.0327","article-title":"Tumor seeding following stereotactic biopsy of brain metastases. Report of two cases","volume":"87","author":"Karlsson","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib76","doi-asserted-by":"crossref","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours","volume":"28","author":"Le Rhun","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib77","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000507","article-title":"How we treat patients with leptomeningeal metastases","volume":"4","author":"Le Rhun","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2021.07.032_bib79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/neuonc\/noz201","article-title":"Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer","volume":"22","author":"Le Rhun","year":"2020","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2021.07.032_bib80","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","article-title":"Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors","volume":"23","author":"Le Rhun","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib81","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-020-0918-0","article-title":"Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis","volume":"26","author":"Brastianos","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2021.07.032_bib82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1759-7714.13712","article-title":"Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer","volume":"12","author":"Mizusaki","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib83","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10549-018-4684-3","article-title":"Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience","volume":"169","author":"Figura","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2021.07.032_bib84","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fonc.2018.00509","article-title":"The comparative treatment of intraventricular chemotherapy by ommaya reservoir vs. Lumbar puncture in patients with leptomeningeal carcinomatosis","volume":"8","author":"Montes de Oca Delgado","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/annonc\/mdy544","article-title":"Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases","volume":"30","author":"Seoane","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib86","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","article-title":"111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases","volume":"50","author":"Mason","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2021.07.032_bib87","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.46.6.1674","article-title":"Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases","volume":"46","author":"Chamberlain","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2021.07.032_bib88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11060-010-0512-2","article-title":"Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis","volume":"104","author":"Lee","year":"2011","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib89","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/mco.2015.627","article-title":"Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: an analysis of 59 cases","volume":"3","author":"Nigim","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib90","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","article-title":"Ventriculoperitoneal shunt in patients with leptomeningeal metastasis","volume":"64","author":"Omuro","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2021.07.032_bib91","first-page":"118","article-title":"Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience","volume":"7","author":"Karschnia","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ejca.2021.07.032_bib92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12957-019-1595-7","article-title":"Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis","volume":"17","author":"Kim","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib93","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/neuros\/nyx420","article-title":"GAVCA study: randomized, multicenter trial to evaluate the quality of ventricular catheter placement with a mobile health assisted guidance technique","volume":"83","author":"Thomale","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2021.07.032_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3171\/2016.8.PEDS16229","article-title":"Ventricular catheter entry site and not catheter tip location predicts shunt survival: a secondary analysis of 3 large pediatric hydrocephalus studies","volume":"19","author":"Whitehead","year":"2017","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ejca.2021.07.032_bib95","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3171\/2011.5.JNS101768","article-title":"Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study","volume":"115","author":"Lin","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib96","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/1971400915609348","article-title":"Extracranial, peritoneal seeding of primary malignant brain tumors through ventriculo-peritoneal shunts in children: case report and review of the literature","volume":"28","author":"Narayan","year":"2015","journal-title":"NeuroRadiol J"},{"key":"10.1016\/j.ejca.2021.07.032_bib97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s003810050166","article-title":"Abdominal metastases of pediatric brain tumors via ventriculo-peritoneal shunts","volume":"14","author":"Rickert","year":"1998","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejca.2021.07.032_bib98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0090-3019(93)90221-L","article-title":"Systemic metastasis of medulloblastoma through ventriculoperitoneal shunt: report of a case and critical analysis of the literature","volume":"40","author":"Jamjoom","year":"1993","journal-title":"Surg Neurol"},{"key":"10.1016\/j.ejca.2021.07.032_bib99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2152-7806.100185","article-title":"Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis","volume":"3","author":"Gonda","year":"2012","journal-title":"Surg Neurol Int"},{"issue":"11","key":"10.1016\/j.ejca.2021.07.032_bib100","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/neuonc\/noaa149","article-title":"Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review","volume":"22","author":"Vogelbaum","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib101","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"Jama"},{"key":"10.1016\/j.ejca.2021.07.032_bib102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-008-9686-2","article-title":"Surgical resection and permanent iodine-125 brachytherapy for brain metastases","volume":"91","author":"Huang","year":"2009","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3171\/jns.2006.105.3.375","article-title":"Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases","volume":"105","author":"Rogers","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib104","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3171\/2014.11.JNS1449","article-title":"Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes","volume":"122","author":"Weil","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.07.032_bib105","article-title":"Resection and surgically targeted radiation therapy for the treatment of larger recurrent or newly diagnosed brain metastasis: results from a prospective trial","volume":"12","author":"Nakaji","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejca.2021.07.032_bib106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02656736.2020.1748238","article-title":"The use of laser interstitial thermal therapy in the treatment of brain metastases: a literature review","volume":"37","author":"Bastos","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ejca.2021.07.032_bib107","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.4103\/2152-7806.181987","article-title":"Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors","volume":"7","author":"Ene","year":"2016","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.ejca.2021.07.032_bib108","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jocn.2014.08.020","article-title":"Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis","volume":"22","author":"Mu","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ejca.2021.07.032_bib109","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11523-019-00645-5","article-title":"Digital PCR-based detection of EGFR mutations in paired plasma and CSF samples of lung adenocarcinoma patients with central nervous system metastases","volume":"14","author":"Huang","year":"2019","journal-title":"Target Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib111","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7150\/thno.36884","article-title":"Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy","volume":"10","author":"von Baumgarten","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejca.2021.07.032_bib112","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/neuonc\/noz156","article-title":"The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors","volume":"21","author":"Mattox","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib113","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2021.07.032_bib114","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10147-014-0760-9","article-title":"Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations","volume":"20","author":"Iuchi","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bpa.12466","article-title":"Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer","volume":"28","author":"Nico\u015b","year":"2018","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ejca.2021.07.032_bib116","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-012-2243-x","article-title":"Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype","volume":"136","author":"Arvold","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2021.07.032_bib117","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.2014.287","article-title":"Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma","volume":"111","author":"Carlino","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2021.07.032_bib118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/neuonc\/nou141","article-title":"Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study","volume":"17","author":"Morikawa","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2021.07.032_bib119","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1158\/1078-0432.CCR-20-1764","article-title":"A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor-positive breast cancer","volume":"26","author":"Tolaney","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2021.07.032_bib120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clbc.2019.07.011","article-title":"Pre- and postoperative neratinib for HER2-positive breast cancer brain metastases: translational breast cancer research consortium 022","volume":"20","author":"Freedman","year":"2020","journal-title":"Clin Breast Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921004901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921004901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:33:08Z","timestamp":1760733188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921004901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":120,"alternative-id":["S0959804921004901"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.07.032","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}